| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |